scorecardresearch Skip to main content

More Life Sciences Headlines

Beam Therapeutics to lay off 100 as it trims costs, narrows research focus

The Cambridge firm is the latest biopharma company in Massachusetts to shed workers in what experts describe as one of the industry’s biggest shakeouts in decades.

Eli Lilly, riding a pharma hot streak, expects to double planned employment in Boston research center

Daniel Skovronsky, Lilly’s chief scientific and medical officer, said the Lilly Institute for Genetic Medicine along Fort Point Channel will ultimately accommodate 500 Lilly scientists and researchers.

Waltham-based Thermo Fisher acquires Swedish company for $3.1 billion

Olink specializes in proteomics, the study of the interactions, function, composition, and structures of proteins and their cellular activities.

Biotech investors push to extend time before pills are subject to price negotiations

Consumer and senior advocates see the lobbying push as another attempt by the pharmaceutical industry to undermine measures to make drugs more affordable for Americans.

EU orders biotech giant Illumina to unwind $7.1 billion purchase of cancer-screening company Grail

The EU already slapped a $475 million fine on Illumina over the summer for jumping the gun on the acquisition without its consent.

Karuna plans to more than double its workforce if schizophrenia drug is approved

Karuna, which began clinical trials of a first-of-its-kind schizophrenia drug called KarXT in 2016, has grown rapidly from about 20 employees in 2020 to more than 300 today.

‘Like playing the lottery’: Laid-off life sciences workers give a snapshot of a cooling-down sector

Thousands of Massachusetts biopharmaceutical workers have been laid off in the past two years in what experts describe as one of the industry’s biggest shakeouts in decades.

FDA rejects Alnylam’s request to expand approval of one of its drugs to include heart patients

The move follows agency scientists and an advisory panel concluding the drug provided only modest benefits to patients.